NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) has 9 SEC Form 4 filings (11 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 2, 2026.
The most active filer is Market Development Director Christianson Mark with 4 filings.
- Industry:Medical - Devices
- CEO:David A. Rosa
- Employees:18
- HQ:Eden Prairie, MN, US
- IPO:2018-03-15
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$44K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$14.4M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Christianson MarkFirst in 3 months | Market Development Director | Sale | 10,000 | $32K | Jul 2 | SEC ↗ |
| Business Development Director | Sale | 15,363 | $11K | Apr 1 | SEC ↗ | |
Christianson MarkFirst filing | Business Development Director | Sale | 817 | $654 | Mar 16 | SEC ↗ |
Christianson MarkFirst filing | Business Development Director | Sale | 100 | $80 | Mar 16 | SEC ↗ |
Related companies
NEUROONE MEDICAL TECHNOLOGIES Corp is in the Healthcare sector.